Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827.
SAIC, HealthEquity And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Why This PepGen Analyst Is Bullish On The Biotech Stock
HC Wainwright initiated coverage of PepGen Inc (NASDAQ:PEPG) with a Buy rating and $26 price target. PepGen is developing next-generation antisense…
Benzinga’s Top Ratings Upgrades, Downgrades For December 21, 2022
Upgrades For PagSeguro Digital Ltd (NYSE:PAGS), New Street Research upgraded the previous rating of Neutral to Buy. In…
HC Wainwright & Co. Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $26
HC Wainwright & Co. analyst Andrew Fein initiates coverage on PepGen (NASDAQ:PEPG) with a Buy rating and announces Price Target of $26.